David R Epstein has bought stock on 15 days since Jun 2019

Director at AgomAb Therapeutics NV, and 4 other companies

SEC CIK 0001445826 · Filings on SEC.gov ↗

$985KBought

$4.1MSold

Oct 22Last buy

David R Epstein's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

18 filings since Jul 2019, newest first

AGMBBuy

AgomAb Therapeutics NV

Director

$89K+66.7%4d ago

AGMBBuy

AgomAb Therapeutics NV

Director

$45K+50.0%Oct 9

AGMBBuy

AgomAb Therapeutics NV

Director

$86KOct 7

SGENSell

Seagen Inc.

CEO

$2.3M−7.0%Nov 13

RUBYBuy

Rubius Therapeutics, Inc.

Director

$43K+1.0%Apr 22

AXLABuy

Axcella Health Inc.

Director

$50K+19.0%Mar 18

RUBYSell

Rubius Therapeutics, Inc.

Director

$399K−1.0%Feb 16

RUBYSell

Rubius Therapeutics, Inc.

Director

$1.5M−2.0%Feb 10

EVLOBuy

Evelo Biosciences, Inc.

Director

$51K+77.0%Dec 14

EVLOBuy

Evelo Biosciences, Inc.

Director

$44KSep 1

AXLABuy

Axcella Health Inc.

Director

$238K+73.0%May 20

RUBYBuy

Rubius Therapeutics, Inc.

Director

$39KMar 17

AXLABuy

Axcella Health Inc.

Director

$54K+28.0%Mar 2

AXLABuy

Axcella Health Inc.

Director

$54K+39.0%Dec 3

AXLABuy

Axcella Health Inc.

Director

$49K+22.0%Aug 5

AXLABuy

Axcella Health Inc.

Director

$48K+24.0%Jul 10

AXLABuy

Axcella Health Inc.

Director

$40K+31.0%Jul 3

AXLABuy

Axcella Health Inc.

Director

$55K+38.0%Jul 1

Filings come from SEC EDGAR. Not investment advice.